表紙
市場調査レポート

北米における培養皮膚(代用皮膚)市場の見通し

North America Tissue Engineered - Skin Substitutes Market Outlook to 2020

発行 GlobalData 商品コード 315204
出版日 ページ情報 英文 123 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
北米における培養皮膚(代用皮膚)市場の見通し North America Tissue Engineered - Skin Substitutes Market Outlook to 2020
出版日: 2014年10月31日 ページ情報: 英文 123 Pages
概要

当レポートでは、北米における培養皮膚(代用皮膚)市場について調査分析し、市場セグメント別の市場規模データ、年間の市場収益・数量・平均販売価格、企業シェア・流通シェアデータ、主要企業プロファイルなどについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 北米における培養皮膚(代用皮膚)市場

  • 培養皮膚(代用皮膚)市場、北米、収益($m)
  • 培養皮膚(代用皮膚)市場、北米、収益別のカテゴリー比較($m)
  • 培養皮膚(代用皮膚)市場、北米、収益実績($m)
  • 培養皮膚(代用皮膚)市場、北米、収益予測($m)
  • 培養皮膚(代用皮膚)市場、北米、数量
  • 培養皮膚(代用皮膚)市場、北米、数量実績
  • 培養皮膚(代用皮膚)市場、北米、数量予測
  • 培養皮膚(代用皮膚)市場、北米、収益別の企業シェア($m)

第4章 カナダの培養皮膚(代用皮膚)市場

  • 培養皮膚(代用皮膚)市場、カナダ、収益実績($m)
  • 培養皮膚(代用皮膚)市場、カナダ、収益予測($m)
  • 培養皮膚(代用皮膚)市場、カナダ、数量実績
  • 培養皮膚(代用皮膚)市場、カナダ、数量予測
  • 培養皮膚(代用皮膚)市場、カナダ、平均販売価格($)
  • 培養皮膚(代用皮膚)市場、カナダ、収益別の流通シェア($m)
  • 培養皮膚(代用皮膚)市場、カナダ、収益別の企業シェア($m)

第5章 メキシコの培養皮膚(代用皮膚)市場

  • 培養皮膚(代用皮膚)市場、メキシコ、収益実績($m)
  • 培養皮膚(代用皮膚)市場、メキシコ、収益予測($m)
  • 培養皮膚(代用皮膚)市場、メキシコ、数量実績
  • 培養皮膚(代用皮膚)市場、メキシコ、数量予測
  • 培養皮膚(代用皮膚)市場、メキシコ、平均販売価格($)
  • 培養皮膚(代用皮膚)市場、メキシコ、収益別の流通シェア($m)
  • 培養皮膚(代用皮膚)市場、メキシコ、収益別の企業シェア($m)

第6章 米国の培養皮膚(代用皮膚)市場

  • 培養皮膚(代用皮膚)市場、米国、収益実績($m)
  • 培養皮膚(代用皮膚)市場、米国、収益予測($m)
  • 培養皮膚(代用皮膚)市場、米国、数量実績
  • 培養皮膚(代用皮膚)市場、米国、数量予測
  • 培養皮膚(代用皮膚)市場、米国、平均販売価格($)
  • 培養皮膚(代用皮膚)市場、米国、収益別の流通シェア($m)
  • 培養皮膚(代用皮膚)市場、米国、収益別の企業シェア($m)

第7章 北米における主要企業の概要、培養皮膚(代用皮膚)市場

  • Organogenesis, Inc.
  • Shire Plc
  • Kinetic Concepts, Inc.
  • Integra LifeSciences Holdings Corporation
  • Smith & Nephew Plc
  • Covidien plc
  • Molnlycke Health Care AB
  • BSN medical GmbH

第8章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECR0232DB

GlobalData's new report, "North America Tissue Engineered - Skin Substitutes Market Outlook to 2020", provides key market data on the North America Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes (Allograft (Cellular and Acellular) and Xenograft Acellular).

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size data for Tissue Engineered - Skin Substitutes market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes.
  • Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
  • 2013 company shares and distribution shares data for Tissue Engineered - Skin Substitutes market.
  • Global corporate-level profiles of key companies operating within the North America Tissue Engineered - Skin Substitutes.
  • Key players covered include Organogenesis, Inc, Kinetic Concepts, Inc. , Shire Plc and Smith & Nephew Plc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Tissue Engineered - Skin Substitutes Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Tissue Engineered - Skin Substitutes Market, North America

  • 3.1. Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), 2005-2020
  • 3.2. Tissue Engineered - Skin Substitutes Market, North America, Category Comparison by Revenue ($m), 2005-2020
  • 3.3. Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), 2005-2013
  • 3.4. Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), 2013-2020
  • 3.5. Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2020
  • 3.6. Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2013
  • 3.7. Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2013-2020
  • 3.8. Tissue Engineered - Skin Substitutes Market, North America, Company Share by Revenue ($m), 2012-2013

4. Tissue Engineered - Skin Substitutes Market, Canada

  • 4.1. Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), 2005-2013
  • 4.2. Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), 2013-2020
    • 4.2.1. Biologic Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2005-2013
      • 4.2.1.1. Allograft Market, Canada, Revenue ($m), by Sub Segment, 2005-2013
    • 4.2.2. Biologic Skin Substitutes Market, Canada, Revenue ($m), by Segment, 2013-2020
      • 4.2.2.1. Allograft Market, Canada, Revenue ($m), by Sub Segment, 2013-2020
  • 4.3. Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), 2005-2013
  • 4.4. Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), 2013-2020
    • 4.4.1. Biologic Skin Substitutes Market, Canada, Volume (Units), by Segment, 2005-2013
      • 4.4.1.1. Allograft Market, Canada, Volume (Units), by Sub Segment, 2005-2013
    • 4.4.2. Biologic Skin Substitutes Market, Canada, Volume (Units), by Segment, 2013-2020
      • 4.4.2.1. Allograft Market, Canada, Volume (Units), by Sub Segment, 2013-2020
  • 4.5. Tissue Engineered - Skin Substitutes Market, Canada, Average Price ($), 2005-2020
  • 4.6. Tissue Engineered - Skin Substitutes Market, Canada, Distribution Share by Revenue ($m), 2012-2013
  • 4.7. Tissue Engineered - Skin Substitutes Market, Canada, Company Share by Revenue ($m), 2012-2013

5. Tissue Engineered - Skin Substitutes Market, Mexico

  • 5.1. Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), 2005-2013
  • 5.2. Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), 2013-2020
    • 5.2.1. Biologic Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2005-2013
      • 5.2.1.1. Allograft Market, Mexico, Revenue ($m), by Sub Segment, 2005-2013
    • 5.2.2. Biologic Skin Substitutes Market, Mexico, Revenue ($m), by Segment, 2013-2020
      • 5.2.2.1. Allograft Market, Mexico, Revenue ($m), by Sub Segment, 2013-2020
  • 5.3. Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), 2005-2013
  • 5.4. Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), 2013-2020
    • 5.4.1. Biologic Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2005-2013
      • 5.4.1.1. Allograft Market, Mexico, Volume (Units), by Sub Segment, 2005-2013
    • 5.4.2. Biologic Skin Substitutes Market, Mexico, Volume (Units), by Segment, 2013-2020
      • 5.4.2.1. Allograft Market, Mexico, Volume (Units), by Sub Segment, 2013-2020
  • 5.5. Tissue Engineered - Skin Substitutes Market, Mexico, Average Price ($), 2005-2020
  • 5.6. Tissue Engineered - Skin Substitutes Market, Mexico, Distribution Share by Revenue ($m), 2012-2013
  • 5.7. Tissue Engineered - Skin Substitutes Market, Mexico, Company Share by Revenue ($m), 2012-2013

6. Tissue Engineered - Skin Substitutes Market, United States

  • 6.1. Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), 2005-2013
  • 6.2. Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), 2013-2020
    • 6.2.1. Biologic Skin Substitutes Market, United States, Revenue ($m), by Segment, 2005-2013
      • 6.2.1.1. Allograft Market, United States, Revenue ($m), by Sub Segment, 2005-2013
    • 6.2.2. Biologic Skin Substitutes Market, United States, Revenue ($m), by Segment, 2013-2020
      • 6.2.1.2. Allograft Market, United States, Revenue ($m), by Sub Segment, 2013-2020
  • 6.3. Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), 2005-2013
  • 6.4. Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), 2013-2020
    • 6.4.1. Biologic Skin Substitutes Market, United States, Volume (Units), by Segment, 2005-2013
      • 6.4.1.1. Allograft Market, United States, Volume (Units), by Sub Segment, 2005-2013
    • 6.4.2. Biologic Skin Substitutes Market, United States, Volume (Units), by Segment, 2013-2020
      • 6.4.1.2. Allograft Market, United States, Volume (Units), by Sub Segment, 2013-2020
  • 6.5. Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), 2005-2020
  • 6.6. Tissue Engineered - Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2012-2013
  • 6.7. Tissue Engineered - Skin Substitutes Market, United States, Company Share by Revenue ($m), 2012-2013

7. Overview of Key Companies in North America Tissue Engineered - Skin Substitutes Market

  • 7.1. Organogenesis, Inc.
    • 7.1.1. Company Overview
  • 7.2. Shire Plc
    • 7.2.1. Company Overview
  • 7.3. Kinetic Concepts, Inc.
    • 7.3.1. Company Overview
  • 7.4. Integra LifeSciences Holdings Corporation
    • 7.4.1. Company Overview
  • 7.5. Smith & Nephew Plc
    • 7.5.1. Company Overview
  • 7.6. Covidien plc
    • 7.6.1. Company Overview
  • 7.7. Molnlycke Health Care AB
    • 7.7.1. Company Overview
  • 7.8. BSN medical GmbH
    • 7.8.1. Company Overview

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Table 2: Tissue Engineered - Skin Substitutes Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Table 3: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Historic, USD Constant, 2005-2013
  • Table 4: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Forecast, USD Constant, 2013-2020
  • Table 5: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2020
  • Table 6: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Historic, 2005-2013
  • Table 7: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Forecast, 2013-2020
  • Table 8: Tissue Engineered - Skin Substitutes Market, North America, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 9: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 10: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 11: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 12: Allograft Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 13: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 14: Allograft Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 15: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Table 16: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Table 17: Biologic Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Table 18: Allograft Market, Canada, Volume (Units), Historic, 2005-2013
  • Table 19: Biologic Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Table 20: Allograft Market, Canada, Volume (Units), Forecast, 2013-2020
  • Table 21: Tissue Engineered - Skin Substitutes Market, Canada, Average Price ($), Historic, 2005-2013
  • Table 22: Tissue Engineered - Skin Substitutes Market, Canada, Average Price ($), Forecast, 2013-2020
  • Table 23: Tissue Engineered - Skin Substitutes Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 24: Tissue Engineered - Skin Substitutes Market, Canada, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 25: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 26: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 27: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 28: Allograft Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 29: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 30: Allograft Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 31: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Table 32: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Table 33: Biologic Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Table 34: Allograft Market, Mexico, Volume (Units), Historic, 2005-2013
  • Table 35: Biologic Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Table 36: Allograft Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Table 37: Tissue Engineered - Skin Substitutes Market, Mexico, Average Price ($), Historic, 2005-2013
  • Table 38: Tissue Engineered - Skin Substitutes Market, Mexico, Average Price ($), Forecast, 2013-2020
  • Table 39: Tissue Engineered - Skin Substitutes Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 40: Tissue Engineered - Skin Substitutes Market, Mexico, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 41: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 42: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 43: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 44: Allograft Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Table 45: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 46: Allograft Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Table 47: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Table 48: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 49: Biologic Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Table 50: Allograft Market, United States, Volume (Units), Historic, 2005-2013
  • Table 51: Biologic Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 52: Allograft Market, United States, Volume (Units), Forecast, 2013-2020
  • Table 53: Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), Historic, 2005-2013
  • Table 54: Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), Forecast, 2013-2020
  • Table 55: Tissue Engineered - Skin Substitutes Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013
  • Table 56: Tissue Engineered - Skin Substitutes Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013
  • Table 57: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020
  • Figure 2: Tissue Engineered - Skin Substitutes Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020
  • Figure 3: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Historic, USD Constant, 2005-2013
  • Figure 4: Tissue Engineered - Skin Substitutes Market, North America, Revenue ($m), Forecast, USD Constant, 2013-2020
  • Figure 5: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), 2005-2020
  • Figure 6: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Historic, 2005-2013
  • Figure 7: Tissue Engineered - Skin Substitutes Market, North America, Volume (Units), Forecast, 2013-2020
  • Figure 8: Tissue Engineered - Skin Substitutes Market, North America, Company Share (%), 2013
  • Figure 9: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 10: Tissue Engineered - Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 11: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 12: Allograft Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 13: Biologic Skin Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 14: Allograft Market, Canada, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 15: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Figure 16: Tissue Engineered - Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Figure 17: Biologic Skin Substitutes Market, Canada, Volume (Units), Historic, 2005-2013
  • Figure 18: Allograft Market, Canada, Volume (Units), Historic, 2005-2013
  • Figure 19: Biologic Skin Substitutes Market, Canada, Volume (Units), Forecast, 2013-2020
  • Figure 20: Allograft Market, Canada, Volume (Units), Forecast, 2013-2020
  • Figure 21: Tissue Engineered - Skin Substitutes Market, Canada, Company Share (%), 2013
  • Figure 22: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 23: Tissue Engineered - Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 24: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 25: Allograft Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 26: Biologic Skin Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 27: Allograft Market, Mexico, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 28: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Figure 29: Tissue Engineered - Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Figure 30: Biologic Skin Substitutes Market, Mexico, Volume (Units), Historic, 2005-2013
  • Figure 31: Allograft Market, Mexico, Volume (Units), Historic, 2005-2013
  • Figure 32: Biologic Skin Substitutes Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Figure 33: Allograft Market, Mexico, Volume (Units), Forecast, 2013-2020
  • Figure 34: Tissue Engineered - Skin Substitutes Market, Mexico, Company Share (%), 2013
  • Figure 35: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 36: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 37: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 38: Allograft Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013
  • Figure 39: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 40: Allograft Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020
  • Figure 41: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 42: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 43: Biologic Skin Substitutes Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 44: Allograft Market, United States, Volume (Units), Historic, 2005-2013
  • Figure 45: Biologic Skin Substitutes Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 46: Allograft Market, United States, Volume (Units), Forecast, 2013-2020
  • Figure 47: Tissue Engineered - Skin Substitutes Market, United States, Company Share (%), 2013
  • Figure 48: GlobalData Epidemiology-Based Forecasting Model
  • Figure 49: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 50: Primary Interviews by Participant Type (%)
Back to Top